article thumbnail

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups

pharmaphorum

.” Conducting this kind of research in Finland makes sense, as it has a sophisticated healthcare system but a small population, which can make it challenging to carry out clinical research using traditional approaches. ” The readouts from the FCT programme are expected to be ready for presentation next year.

Trials 69
article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Food and Drug Administration approval.